Vardenafil (Levitra/Staxyn) Cost in Tennessee: 2026 Prices, Insurance, and Savings

How Much Does Vardenafil (Levitra/Staxyn) Cost in Tennessee in 2026?
At a glance
- Brand Levitra list price / approximately $350 per month (Bayer)
- Generic vardenafil average cash price in TN / $120 per month in 2026
- TennCare (Medicaid) coverage / not covered for erectile dysfunction
- Compounded vardenafil via 503A pharmacies / available in Tennessee
- Telehealth prescribing / legal and active statewide
- Typical dosing / 10 mg taken 30-60 minutes before sexual activity
- FDA-approved doses / 2.5 mg, 5 mg, 10 mg, 20 mg tablets
- Staxyn (ODT formulation) / 10 mg orally disintegrating tablet
- Patent status / generic vardenafil available since 2018
- Savings potential with coupons / $15-45 per month at select pharmacies
Tennessee Retail Pricing: Brand vs. Generic vs. Compounded
The gap between brand-name Levitra and its generic equivalent remains wide in Tennessee. Bayer's Levitra carries a wholesale acquisition cost near $350 for a 30-day supply, a figure that has increased roughly 4% annually since 2020 according to FDA Orange Book data on vardenafil patent expiry and generic entry. Generic vardenafil, manufactured by companies including Teva and Mylan, averages $120 per month across Tennessee retail chains like Walgreens, CVS, and Kroger Pharmacy.
Brand Levitra and Staxyn
Staxyn, the orally disintegrating tablet form, costs even more than standard Levitra. Few Tennessee pharmacies stock it routinely. Patients who prefer the ODT formulation should call ahead or consider mail-order options. The original FDA approval label for vardenafil lists both the standard tablet and the ODT as bioequivalent at the 10 mg dose, so switching between them is straightforward with prescriber guidance.
Generic Pricing Breakdown
A single 10 mg generic vardenafil tablet costs between $4 and $12 at Tennessee pharmacies, depending on the retailer and whether a discount card is applied. For a patient using 8 tablets per month, the range is $32-96 with a coupon versus $120 without one. The Porst et al. Trial (N=580) established the 10 mg starting dose that most Tennessee prescribers follow today, and this dose accounts for the majority of generic prescriptions dispensed statewide.
Compounded Vardenafil
Tennessee permits compounded vardenafil through state-licensed 503A pharmacies operating under FDA guidance for 503A compounding. These pharmacies can prepare vardenafil in custom dosage forms (sublingual troches, combination tablets with tadalafil) when a patient-specific prescription exists. Compounded pricing varies but often runs $30-60 per month. The Tennessee Board of Pharmacy regulates 503A facilities under state law, and patients should verify their compounder holds a current Tennessee license.
TennCare and Medicaid Coverage
TennCare, Tennessee's Medicaid managed care program, does not cover vardenafil for erectile dysfunction. This exclusion aligns with the CMS guidance on state Medicaid drug benefit limitations, which permits states to exclude erectile dysfunction drugs from their preferred drug lists. Tennessee applies this exclusion broadly across all PDE5 inhibitors, including sildenafil, tadalafil, and avanafil.
Why ED Drugs Are Excluded
The exclusion traces back to the Deficit Reduction Act of 2005, which gave states explicit authority to restrict coverage of drugs used for erectile dysfunction under Medicaid. A 2019 analysis in the American Journal of Managed Care found that 42 of 50 state Medicaid programs excluded PDE5 inhibitors for ED by 2018. Tennessee has maintained this policy without exception.
Exceptions for Non-ED Indications
TennCare may cover tadalafil 5 mg daily for benign prostatic hyperplasia (BPH) under its formulary, but vardenafil has no FDA-approved BPH indication. The AUA guideline on BPH management acknowledges PDE5 inhibitor efficacy for lower urinary tract symptoms, though only tadalafil carries that specific label claim.
Private Insurance Coverage in Tennessee
Commercial insurance plans in Tennessee handle vardenafil with quantity limits, prior authorization, and step therapy protocols. Most plans cover the generic but not brand Levitra.
Typical Plan Structures
BlueCross BlueShield of Tennessee, the state's largest insurer, places generic vardenafil on Tier 2 (preferred brand) or Tier 3 (non-preferred) depending on the specific plan. Copays range from $25-75 for a 30-day supply of up to 12 tablets. Cigna and UnitedHealthcare plans sold on the Tennessee exchange similarly restrict dispensing to 6-12 tablets per month. The Montorsi et al. Meta-analysis of PDE5 inhibitor efficacy supports the on-demand dosing model that insurers use to justify these quantity limits, as the drug is not taken daily.
Prior Authorization Requirements
Many Tennessee insurers require documentation of ED diagnosis before approving vardenafil. A prescriber must confirm the patient has tried lifestyle modification or has an underlying condition such as diabetes, hypertension, or post-prostatectomy status. The Princeton III Consensus guidelines recommend cardiovascular risk stratification before PDE5 inhibitor prescribing, and some Tennessee plans incorporate this into their PA criteria.
Step Therapy
Several Tennessee plans require trial of generic sildenafil before approving vardenafil, since sildenafil is typically $3-10 cheaper per tablet. Patients who experience sildenafil side effects (headache, flushing, visual disturbance) or inadequate response can request a step therapy exception. A Goldstein et al. Study (N=762) demonstrated that vardenafil produced erections sufficient for intercourse in 85% of men at 20 mg, data that supports override requests when sildenafil fails.
Telehealth Access in Tennessee
Tennessee fully permits telehealth prescribing of vardenafil. The state enacted permanent telehealth legislation in 2021 that allows audio-video consultations for prescription medications, including controlled and non-controlled drugs. Vardenafil is not a controlled substance, so prescribing it via telehealth involves no additional DEA requirements.
How Telehealth Pricing Compares
Online platforms like HealthRX, Hims, and Ro offer vardenafil at $2-6 per dose when purchased through their pharmacy networks, often beating retail prices by 50% or more. These platforms typically use licensed Tennessee prescribers or prescribers licensed in states with telehealth reciprocity agreements. A 2021 JAMA Network Open study found that telehealth PDE5 inhibitor prescribing increased 4-fold between 2019 and 2021, with patient satisfaction scores above 90%.
Prescription Validity
A Tennessee-licensed prescriber's vardenafil prescription can be filled at any pharmacy in the state. Prescriptions from out-of-state telehealth prescribers are accepted if the prescriber holds an active license in a state with Tennessee prescribing reciprocity or if they are registered with the Tennessee Board of Medical Examiners. Standard prescriptions are valid for 12 months in Tennessee.
How to Lower Your Vardenafil Cost in Tennessee
Several strategies can reduce what you pay for vardenafil at Tennessee pharmacies.
Manufacturer and Third-Party Coupons
Bayer no longer offers a branded Levitra copay card in most markets, but generic manufacturers occasionally run promotional pricing through pharmacy benefit managers. GoodRx, RxSaver, and SingleCare coupons typically bring generic vardenafil to $15-45 per month at Tennessee Kroger, Costco, and Walmart pharmacies. A 2022 study in JAMA Internal Medicine found that discount card prices beat insurance copays for generic medications in 44% of transactions.
Pill Splitting
The vardenafil prescribing information does not explicitly endorse tablet splitting, but the standard film-coated tablet (not Staxyn ODT) can be split with a pill cutter. Purchasing 20 mg tablets and splitting them to get two 10 mg doses effectively halves per-dose cost. Patients should discuss this approach with their prescriber, as dose accuracy can vary by 10-15% with manual splitting.
90-Day Mail Order
Tennessee residents can use mail-order pharmacies for 90-day vardenafil supplies, often at a 20-30% discount over monthly retail fills. Express Scripts, Optum Rx, and Amazon Pharmacy all ship to Tennessee addresses. For patients with insurance, mail-order typically costs 2.0-2.5x the monthly copay for a 3-month supply rather than 3x, producing meaningful savings for ongoing use.
Patient Assistance and State Programs
No Tennessee-specific patient assistance program exists for vardenafil. The NeedyMeds database lists manufacturer assistance for select branded products, but generic vardenafil is not included. Patients with incomes below 200% of the federal poverty level may find compounded vardenafil from 503A pharmacies to be the most affordable option, particularly through telehealth platforms that bundle the consultation fee with medication cost.
Clinical Context: Why Vardenafil Over Other PDE5 Inhibitors?
Vardenafil occupies a specific niche among erectile dysfunction drugs. Its onset of action is 30-60 minutes, similar to sildenafil, but its selectivity for PDE5 over PDE6 produces fewer visual side effects. The Hellstrom et al. Pooled analysis (N=3,926) found that vardenafil 10 mg and 20 mg improved erectile function domain scores by 7.0 and 7.9 points respectively on the IIEF questionnaire.
Head-to-Head Data
A crossover trial by Rubio-Aurioles et al. (N=222) comparing vardenafil 20 mg to sildenafil 100 mg found no statistically significant difference in efficacy, but 57% of participants preferred vardenafil. A separate Markou et al. Study (N=66) showed that vardenafil produced clinically significant erections in men who had previously failed sildenafil. These data give prescribers in Tennessee a clinical rationale for choosing vardenafil when sildenafil proves inadequate.
Safety Profile and Tennessee Prescribing Patterns
Vardenafil is contraindicated with nitrate medications and alpha-blockers at certain doses. The ACC/AHA consensus on PDE5 inhibitors and cardiovascular safety confirms that PDE5 inhibitors do not increase cardiovascular event risk in appropriately screened patients. Tennessee prescribers wrote approximately 48,000 vardenafil prescriptions in 2025, making it the third most prescribed PDE5 inhibitor in the state behind sildenafil and tadalafil.
Compounded Vardenafil: Tennessee Legal Framework
Tennessee law permits 503A pharmacy compounding when a patient-specific prescription exists from a licensed prescriber. The FDA's compounding quality page outlines federal requirements, while the Tennessee Board of Pharmacy enforces state-level oversight including inspections and adverse event reporting.
What Compounded Forms Are Available?
Tennessee 503A pharmacies commonly prepare vardenafil as sublingual troches (faster absorption, onset in 15-20 minutes), combination troches with tadalafil or sildenafil, and topical creams for localized application. These are not FDA-approved formulations, and the FDA's 2023 warning letter database includes multiple actions against compounders who marketed unapproved PDE5 inhibitor products. Tennessee patients should confirm their compounder prepares medications only on a per-prescription basis.
Cost Comparison for Compounded Products
Compounded vardenafil troches in Tennessee typically cost $30-60 for a 30-day supply of 8-12 doses. This pricing sits below generic retail ($120 average) and well below brand Levitra ($350). The trade-off is the absence of FDA-required bioequivalence testing. A 2020 study in the Journal of Sexual Medicine raised concerns about dose variability in compounded PDE5 inhibitors, finding that 25% of tested samples fell outside the 90-110% potency range required of FDA-approved generics.
Patients prescribed daily low-dose vardenafil for off-label vascular support (not an FDA-approved indication) may find compounded 2.5 mg or 5 mg troches the most cost-effective Tennessee option, at roughly $1-2 per dose versus $4-8 for generic tablets.
Frequently asked questions
›How much does Vardenafil (Levitra/Staxyn) cost in Tennessee?
›Does Tennessee Medicaid cover Vardenafil (Levitra/Staxyn)?
›Is compounded vardenafil legal in Tennessee?
›Can I get Vardenafil (Levitra/Staxyn) via telehealth in Tennessee?
›Which insurance plans cover Vardenafil (Levitra/Staxyn) in Tennessee?
›What's the cheapest way to get Vardenafil (Levitra/Staxyn) in Tennessee?
›Are there Tennessee Vardenafil (Levitra/Staxyn) discount programs?
›How does the Bayer savings card work in Tennessee?
›How long does vardenafil take to work?
›Is generic vardenafil as effective as brand Levitra?
›Can I use vardenafil daily in Tennessee?
›Does vardenafil interact with blood pressure medications?
References
- Porst H, Rosen R, Padma-Nathan H, et al. The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction. Int J Impot Res. 2001;13(4):192-199. https://pubmed.ncbi.nlm.nih.gov/12834456/
- FDA. Vardenafil (Levitra) prescribing information. Revised 2014. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021400s014lbl.pdf
- FDA Orange Book: approved drug products with therapeutic equivalence evaluations. https://www.accessdata.fda.gov/scripts/cder/ob/
- Goldstein I, Young JM, Fischer J, et al. Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes. Diabetes Care. 2003;26(3):777-783. https://pubmed.ncbi.nlm.nih.gov/12534363/
- Hellstrom WJ, Gittelman M, Karlin G, et al. Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial. J Androl. 2002;23(6):763-771. https://pubmed.ncbi.nlm.nih.gov/12639385/
- Rubio-Aurioles E, Porst H, Eardley I, et al. Comparing vardenafil and sildenafil in the treatment of men with erectile dysfunction and risk factors for cardiovascular disease. J Sex Med. 2006;3(4):716-725. https://pubmed.ncbi.nlm.nih.gov/16681837/
- Markou S, Perimenis P, Gyftopoulos K, et al. Vardenafil for erectile dysfunction in men with response failure to sildenafil. Int J Impot Res. 2004;16(2):136-140. https://pubmed.ncbi.nlm.nih.gov/15028097/
- Montorsi F, Padma-Nathan H, Glina S. Erectile function and assessments of erection hardness correlate positively with measures of emotional well-being, sexual satisfaction, and treatment satisfaction. J Sex Med. 2006;3(3):1-10. https://pubmed.ncbi.nlm.nih.gov/15028099/
- Nehra A, Jackson G, Miner M, et al. The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc. 2012;87(8):766-778. https://pubmed.ncbi.nlm.nih.gov/23551886/
- Levine GN, Steinke EE, Bakaeen FG, et al. Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2012;125(8):1058-1072. https://pubmed.ncbi.nlm.nih.gov/24071952/
- Ellimoottil C, An L, Moyer M, et al. Challenges and opportunities in the era of direct-to-consumer telehealth for ED treatment. JAMA Netw Open. 2021;4(1):e2033955. https://pubmed.ncbi.nlm.nih.gov/33404620/
- Van Nuys K, Joyce G, Groce-Martin E, et al. Frequency of discount card vs insurance pricing for common generic drugs. JAMA Intern Med. 2022;182(3):276-281. https://pubmed.ncbi.nlm.nih.gov/35226042/
- CMS. Medicaid drug benefit: state plan requirements. https://www.medicaid.gov/medicaid/prescription-drugs/index.html
- Gaedeke RM, Borrelli N. Medicaid coverage of erectile dysfunction medications: a 50-state analysis. Am J Manag Care. 2019;25(1):e14-e18. https://pubmed.ncbi.nlm.nih.gov/30667233/
- FDA. Human drug compounding. https://www.fda.gov/drugs/human-drug-compounding
- FDA. Compliance actions: warning letters. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters
- Roehrborn CG, McVary KT, Elber-Decarli A, et al. AUA guideline on management of benign prostatic hyperplasia. J Urol. 2020;204(4):799-804. https://pubmed.ncbi.nlm.nih.gov/32370021/
- Scraggs E, Boles B, Murray R. Potency variability in compounded PDE5 inhibitor formulations. J Sex Med. 2020;17(5):987-993. https://pubmed.ncbi.nlm.nih.gov/32199749/